{"id":5506,"date":"2025-04-12T13:17:41","date_gmt":"2025-04-12T09:47:41","guid":{"rendered":"https:\/\/www.alhavipharma.com\/?page_id=5506"},"modified":"2025-10-28T01:18:28","modified_gmt":"2025-10-27T21:48:28","slug":"empajent10-5","status":"publish","type":"page","link":"https:\/\/www.alhavipharma.com\/en\/empajent10-5\/","title":{"rendered":"Empajent 10\/5"},"content":{"rendered":"<section class=\"l-section wpb_row us_custom_b91424ac height_medium\"><div class=\"l-section-h i-cf\"><div class=\"g-cols vc_row via_grid cols_7-5 laptops-cols_inherit tablets-cols_inherit mobiles-cols_1 valign_top type_default stacking_default\"><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"g-cols wpb_row via_grid cols_1 laptops-cols_inherit tablets-cols_inherit mobiles-cols_1 valign_top type_default stacking_default\"><div class=\"wpb_column vc_column_container us_custom_72fc42ef\"><div class=\"vc_column-inner\"><\/div><\/div><\/div>[vc_custom_heading text=&#8221;Empajent 10\/5 (Empagliflozin + Linagliptin)&#8221; font_container=&#8221;tag:h1|text_align:left&#8221; use_theme_fonts=&#8221;yes&#8221; css=&#8221;.vc_custom_1730040002{margin-bottom:12px !important;}&#8221;]<div class=\"wpb_text_column us_custom_3725e9ff\"><div class=\"wpb_wrapper\"><p>Empajent 10\/5 is a fixed-dose combination tablet containing **Empagliflozin (SGLT2 inhibitor)** and **Linagliptin (DPP-4 inhibitor)**, produced by Alhavi Pharmaceutical \u2014 the first manufacturer of this combination in Iran.<br \/>\nIt is used to control blood glucose levels in adults with type 2 diabetes mellitus.<br \/>\nThe complementary mechanisms of both active ingredients help improve glycemic control \u2014 Empagliflozin by increasing urinary glucose excretion, and Linagliptin by enhancing insulin secretion and reducing hepatic glucose production.<br \/>\nEmpajent is available in two strengths: **10\/5 mg** and **25\/5 mg** tablets.<\/p>\n<\/div><\/div><div class=\"wpb_text_column us_custom_6e987a3d\"><div class=\"wpb_wrapper\"><p>Dosage form: Tablet<\/p>\n<\/div><\/div><\/div><\/div><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"w-image align_none\"><div url class=\"w-image-h\"><img loading=\"lazy\" decoding=\"async\" width=\"600\" height=\"600\" src=\"https:\/\/www.alhavipharma.com\/en\/wp-content\/uploads\/2025\/10\/Empajent-10.png\" class=\"attachment-large size-large\" alt=\"\" srcset=\"https:\/\/www.alhavipharma.com\/en\/wp-content\/uploads\/2025\/10\/Empajent-10.png 600w, https:\/\/www.alhavipharma.com\/en\/wp-content\/uploads\/2025\/10\/Empajent-10-300x300.png 300w, https:\/\/www.alhavipharma.com\/en\/wp-content\/uploads\/2025\/10\/Empajent-10-150x150.png 150w\" sizes=\"auto, (max-width: 600px) 100vw, 600px\" \/><\/div><\/div><\/div><\/div><\/div><\/div><\/section><section class=\"l-section wpb_row us_custom_6217dcc9 height_medium\"><div class=\"l-section-h i-cf\"><div class=\"g-cols vc_row via_grid cols_1 laptops-cols_inherit tablets-cols_inherit mobiles-cols_1 valign_top type_default stacking_default\"><div class=\"wpb_column vc_column_container\"><div class=\"vc_column-inner\"><div class=\"w-tabs us_custom_00310b13 layout_hor style_default switch_click has_scrolling\" style=\"--sections-title-size:1em\"><div class=\"w-tabs-list items_2 align_none\"><div class=\"w-tabs-list-h\"><button class=\"w-tabs-item active\" aria-controls=\"content-bfbd\" aria-expanded=\"false\"><span class=\"w-tabs-item-title\">Overview<\/span><\/button><button class=\"w-tabs-item\" aria-controls=\"content-t310\" aria-expanded=\"false\"><span class=\"w-tabs-item-title\">Directions for Use<\/span><\/button><\/div><\/div><div class=\"w-tabs-sections titles-align_none icon_chevron cpos_right\"><div class=\"w-tabs-section active\" id=\"bfbd\"><button class=\"w-tabs-section-header active\" aria-controls=\"content-bfbd\" aria-expanded=\"true\"><div class=\"w-tabs-section-title\">Overview<\/div><div class=\"w-tabs-section-control\"><\/div><\/button><div  class=\"w-tabs-section-content\" id=\"content-bfbd\"><div class=\"w-tabs-section-content-h i-cf\"><div class=\"wpb_text_column us_custom_bfe97582\"><div class=\"wpb_wrapper\"><p>Empajent is indicated for:<br \/>\n\u2022 Control of blood glucose levels in adults with type 2 diabetes mellitus requiring combination therapy with Empagliflozin and Linagliptin<br \/>\n\u2022 Can be used as an adjunct to diet and exercise, either alone or with other antidiabetic agents<br \/>\nThis dual mechanism enhances glycemic control by promoting urinary glucose excretion and improving pancreatic insulin response.<\/p>\n<\/div><\/div><\/div><\/div><\/div><div class=\"w-tabs-section\" id=\"t310\"><button class=\"w-tabs-section-header\" aria-controls=\"content-t310\" aria-expanded=\"false\"><div class=\"w-tabs-section-title\">Directions for Use<\/div><div class=\"w-tabs-section-control\"><\/div><\/button><div  class=\"w-tabs-section-content\" id=\"content-t310\"><div class=\"w-tabs-section-content-h i-cf\"><div class=\"wpb_text_column us_custom_bf054df1\"><div class=\"wpb_wrapper\"><p>\u2022 Recommended dose (10\/5 mg): one tablet once daily<br \/>\n\u2022 Can be taken in the morning, with or without food<br \/>\n\u2022 Swallow the tablet whole with water \u2014 do not crush or chew<br \/>\n\u2022 Continue regular blood glucose monitoring and follow dietary and exercise recommendations<br \/>\n\u2022 Use under medical supervision, especially in patients with kidney or liver impairment<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section>\n","protected":false},"excerpt":{"rendered":"[vc_custom_heading text=\"Empajent 10\/5 (Empagliflozin + Linagliptin)\" font_container=\"tag:h1|text_align:left\" use_theme_fonts=\"yes\" css=\".vc_custom_1730040002{margin-bottom:12px !important;}\"]Empajent 10\/5 is a fixed-dose combination tablet containing **Empagliflozin (SGLT2 inhibitor)** and **Linagliptin (DPP-4 inhibitor)**, produced by Alhavi Pharmaceutical \u2014 the first manufacturer of this combination in Iran. It is used to control blood glucose levels in adults with type 2 diabetes mellitus. The complementary mechanisms...","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"class_list":["post-5506","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.alhavipharma.com\/en\/wp-json\/wp\/v2\/pages\/5506","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.alhavipharma.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.alhavipharma.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.alhavipharma.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.alhavipharma.com\/en\/wp-json\/wp\/v2\/comments?post=5506"}],"version-history":[{"count":4,"href":"https:\/\/www.alhavipharma.com\/en\/wp-json\/wp\/v2\/pages\/5506\/revisions"}],"predecessor-version":[{"id":6203,"href":"https:\/\/www.alhavipharma.com\/en\/wp-json\/wp\/v2\/pages\/5506\/revisions\/6203"}],"wp:attachment":[{"href":"https:\/\/www.alhavipharma.com\/en\/wp-json\/wp\/v2\/media?parent=5506"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}